The historical rank and industry rank for Arvaya Healthcare's ROE % or its related term are showing as below:
BOM:524723'
s ROE % Range Over the Past 10 Years
Min: -11.9 Med: -2.34 Max: 3.93
Current: 2.25
During the past 13 years, Arvaya Healthcare's highest ROE % was 3.93%. The lowest was -11.90%. And the median was -2.34%.
BOM:524723's ROE % is ranked worse than 71.68% of 113
companies
in the Medical Distribution industry
Industry Median: 7.1
vs BOM:524723: 2.25
Arvaya Healthcare (BOM:524723) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Arvaya Healthcare ROE % Related Terms
Arvaya Healthcare ROE % Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arvaya Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's ROE % distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Arvaya Healthcare (BOM:524723) has a ROE % of 8.46% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #81 out of 113 companies in the Medical Distribution industry, placing it in the top 71.7%.
Is Arvaya Healthcare's ROE % too high?
Arvaya Healthcare's current ROE % is 8.46%. The Medical Distribution industry median ROE % is 7.10. Arvaya Healthcare's value of 8.46% is 19.2% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #81 out of 113 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Arvaya Healthcare has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's ROE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #81 out of 113 companies for ROE %. This places Arvaya Healthcare in the lower half of its industry. The industry median ROE % is 7.10. Arvaya Healthcare's value of 8.46% is 19.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current ROE % of 8.46% is 19.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current ROE % is 8.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.10, compared to a current price of ₹67.11 — trading 36.7% above its estimated fair value. The current ROE % is 8.46% and 19.2% above the Medical Distribution industry median of 7.10. Arvaya Healthcare's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current ROE % is 8.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹67.11 is trading 36.7% above its estimated GF Value™ of ₹49.10.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
ROE %: 8.46%
GF Value™: ₹49.10 vs. price of ₹67.11 (36.7% above fair value)
Industry Position: 19.2% above the Medical Distribution median (#81 of 113)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
49GF Score
Get the complete analysis for BOM:524723
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
